Skip to main content
. 2021 Jun 4;18:117. doi: 10.1186/s12985-021-01588-y

Fig. 2.

Fig. 2

Levels of inflammatory cytokines in healthy controls and in COVID-19 patients at admission who did or did not develop ARDS. The levels of all 4 cytokines were significantly higher among ARDS patients than in the control group (ad). The ARDS group had higher levels of IL-6, IL-8, and IL-10 than the non-ARDS group (ac). Compared to control group, the non-ARDS group had higher levels of IL-6 and TNF-α (a, d). (*p < 0.05, **p < 0.01, ***p < 0.001)